# AI Financial Corp: financial statements, quarterly AIFC · Nasdaq · CIK 862861 · [Financials](/sectors/financials.md) · fiscal year ends Dec 26 Pages: [Overview](/companies/aifc.md) · [Financials](/companies/aifc/financials.md) · [Filings](/companies/aifc/filings.md) · [Insiders](/companies/aifc/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aifc/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.0](/filings/0001628280-24-047204.md) | [0.0 d](/filings/0001628280-25-015469.md) | [0.0](/filings/0001628280-25-025004.md) | [2.2](/filings/0001628280-25-039914.md) | [4.9](/filings/0001628280-26-001793.md) | [4.8 d](/filings/0001493152-26-016259.md) | [4.8](/filings/0001493152-26-024169.md) | [6.4](/filings/0001493152-26-038732.md) | [7.6](/filings/0001628280-26-001793.md) | [5.4 d](/filings/0001493152-26-016259.md) | [4.7](/filings/0001493152-26-024169.md) | [2.4](/filings/0001493152-26-038732.md) | | Cost of revenue | $m | [0.0](/filings/0001628280-24-047204.md) | [0.0 d](/filings/0001628280-25-015469.md) | [0.0](/filings/0001628280-25-025004.md) | [1.1](/filings/0001628280-25-039914.md) | [2.6](/filings/0001628280-26-001793.md) | [2.6 d](/filings/0001493152-26-016259.md) | [2.9](/filings/0001493152-26-024169.md) | [3.6](/filings/0001493152-26-038732.md) | [5.0](/filings/0001628280-26-001793.md) | [3.2 d](/filings/0001493152-26-016259.md) | [1.1](/filings/0001493152-26-024169.md) | [0.1](/filings/0001493152-26-038732.md) | | Gross profit | $m | [0.0](/filings/0001628280-24-047204.md) | [0.0 d](/filings/0001628280-25-015469.md) | [0.0](/filings/0001628280-25-025004.md) | [1.1](/filings/0001628280-25-039914.md) | [2.4](/filings/0001628280-26-001793.md) | [2.2 d](/filings/0001493152-26-016259.md) | [1.9](/filings/0001493152-26-024169.md) | [2.8](/filings/0001493152-26-038732.md) | [2.6](/filings/0001628280-26-001793.md) | [2.2 d](/filings/0001493152-26-016259.md) | [3.6](/filings/0001493152-26-024169.md) | [2.4](/filings/0001493152-26-038732.md) | | Selling, general and administrative | $m | [0.8](/filings/0001628280-24-047204.md) | [1.8 d](/filings/0001628280-25-015469.md) | [1.8](/filings/0001628280-25-025004.md) | [3.5](/filings/0001628280-25-039914.md) | [3.1](/filings/0001628280-26-001793.md) | [4.8 d](/filings/0001493152-26-016259.md) | [3.9](/filings/0001493152-26-024169.md) | [4.9](/filings/0001493152-26-038732.md) | [19.2](/filings/0001628280-26-001793.md) | [4.8 d](/filings/0001493152-26-016259.md) | [6.3](/filings/0001493152-26-024169.md) | [3.1](/filings/0001493152-26-038732.md) | | Operating income | $m | [(0.8)](/filings/0001628280-24-047204.md) | [(16.9) d](/filings/0001628280-25-015469.md) | [(1.8)](/filings/0001628280-25-025004.md) | [(2.4)](/filings/0001628280-25-039914.md) | [(0.7)](/filings/0001628280-26-001793.md) | [(2.6) d](/filings/0001493152-26-016259.md) | [(1.9)](/filings/0001493152-26-024169.md) | [(2.1)](/filings/0001493152-26-038732.md) | [(16.5)](/filings/0001628280-26-001793.md) | [(2.6) d](/filings/0001493152-26-016259.md) | [(2.7)](/filings/0001493152-26-024169.md) | [(0.7)](/filings/0001493152-26-038732.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [(0.0)](/filings/0001628280-24-047204.md) | [(0.2) d](/filings/0001628280-25-015469.md) | [(0.1)](/filings/0001628280-25-025004.md) | [(2.8)](/filings/0001628280-25-039914.md) | [(0.4)](/filings/0001628280-26-001793.md) | [2.9 d](/filings/0001493152-26-016259.md) | [(0.2)](/filings/0001493152-26-024169.md) | [0.4](/filings/0001493152-26-038732.md) | [12.1](/filings/0001628280-26-001793.md) | [(98.7) d](/filings/0001493152-26-016259.md) | [(85.1)](/filings/0001493152-26-024169.md) | [(57.1)](/filings/0001493152-26-038732.md) | | Net income | $m | [(0.2)](/filings/0001628280-24-047204.md) | [(17.8) d](/filings/0001628280-25-015469.md) | [(2.1)](/filings/0001628280-25-025004.md) | [0.6](/filings/0001628280-25-039914.md) | [(0.8)](/filings/0001628280-26-001793.md) | [(5.2) d](/filings/0001493152-26-016259.md) | [(2.4)](/filings/0001493152-26-024169.md) | [(9.1)](/filings/0001493152-26-038732.md) | [49.0](/filings/0001628280-26-001793.md) | [(381) d](/filings/0001493152-26-016259.md) | [(271)](/filings/0001493152-26-024169.md) | [(230)](/filings/0001493152-26-038732.md) | | Diluted EPS | $ per share | [(0.05)](/filings/0001628280-24-047204.md) | not reported | [(0.34)](/filings/0001628280-25-025004.md) | [0.07](/filings/0001628280-25-039914.md) | [(0.06)](/filings/0001628280-26-001793.md) | not reported | [(0.15)](/filings/0001493152-26-024169.md) | [(0.49)](/filings/0001493152-26-038732.md) | [0.29](/filings/0001628280-26-001793.md) | not reported | [(2.14)](/filings/0001493152-26-024169.md) | [(1.68)](/filings/0001493152-26-038732.md) | | Basic EPS | $ per share | [(0.05)](/filings/0001628280-24-047204.md) | not reported | [(0.34)](/filings/0001628280-25-025004.md) | [0.07](/filings/0001628280-25-039914.md) | [(0.06)](/filings/0001628280-26-001793.md) | not reported | [(0.15)](/filings/0001493152-26-024169.md) | [(0.49)](/filings/0001493152-26-038732.md) | [0.67](/filings/0001628280-26-001793.md) | not reported | [(2.14)](/filings/0001493152-26-024169.md) | [(1.68)](/filings/0001493152-26-038732.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [0.4](/filings/0001628280-23-038956.md) | [0.0](/filings/0001628280-25-015469.md) | [0.1](/filings/0001628280-24-020286.md) | [5.8](/filings/0001628280-24-037717.md) | [8.7](/filings/0001628280-24-047204.md) | [7.2](/filings/0001493152-26-016259.md) | [10.8](/filings/0001628280-25-025004.md) | [9.6](/filings/0001628280-25-039914.md) | [7.3](/filings/0001628280-26-001793.md) | [6.2](/filings/0001493152-26-038732.md) | [10.5](/filings/0001493152-26-024169.md) | [3.1](/filings/0001493152-26-038732.md) | | Current assets | $m | [0.5](/filings/0001628280-23-038956.md) | [0.3](/filings/0001628280-25-015469.md) | [1.2](/filings/0001628280-24-020286.md) | [30.9](/filings/0001628280-24-037717.md) | [31.9](/filings/0001628280-24-047204.md) | [34.4](/filings/0001493152-26-016259.md) | [31.8](/filings/0001628280-25-025004.md) | [14.9](/filings/0001493152-26-038732.md) | [44.8](/filings/0001628280-26-001793.md) | [29.5](/filings/0001493152-26-038732.md) | [32.2](/filings/0001493152-26-024169.md) | [14.9](/filings/0001493152-26-038732.md) | | Total assets | $m | [34.5](/filings/0001628280-23-038956.md) | [18.5](/filings/0001628280-25-015469.md) | [18.6](/filings/0001628280-24-020286.md) | [75.4](/filings/0001628280-24-037717.md) | [74.9](/filings/0001628280-24-047204.md) | [75.7](/filings/0001493152-26-016259.md) | [78.0](/filings/0001628280-25-025004.md) | [94.7](/filings/0001628280-25-039914.md) | [1,640](/filings/0001628280-26-001793.md) | [1,219](/filings/0001493152-26-038732.md) | [960](/filings/0001493152-26-024169.md) | [724](/filings/0001493152-26-038732.md) | | Current liabilities | $m | [2.5](/filings/0001628280-23-038956.md) | [5.9](/filings/0001628280-25-015469.md) | [8.1](/filings/0001628280-24-020286.md) | [42.5](/filings/0001628280-24-037717.md) | [42.3](/filings/0001628280-24-047204.md) | [40.9](/filings/0001493152-26-016259.md) | [38.2](/filings/0001628280-25-025004.md) | [24.9](/filings/0001493152-26-038732.md) | [56.4](/filings/0001628280-26-001793.md) | [51.4](/filings/0001493152-26-038732.md) | [39.1](/filings/0001493152-26-024169.md) | [24.9](/filings/0001493152-26-038732.md) | | Total liabilities | $m | [5.5](/filings/0001628280-23-038956.md) | [7.3](/filings/0001628280-25-015469.md) | [10.9](/filings/0001628280-24-020286.md) | [48.6](/filings/0001628280-24-037717.md) | [50.8](/filings/0001628280-24-047204.md) | [55.8](/filings/0001493152-26-016259.md) | [48.8](/filings/0001628280-25-025004.md) | [61.6](/filings/0001628280-25-039914.md) | [80.1](/filings/0001628280-26-001793.md) | [60.3](/filings/0001493152-26-038732.md) | [62.6](/filings/0001493152-26-024169.md) | [48.4](/filings/0001493152-26-038732.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.6](/filings/0001493152-26-016259.md) | not reported | not reported | not reported | [0.6](/filings/0001493152-26-038732.md) | [0.1](/filings/0001493152-26-024169.md) | [0.1](/filings/0001493152-26-038732.md) | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Short-term borrowings | $m | [0.0](/filings/0001628280-23-038956.md) | [0.0](/filings/0001628280-24-015260.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [14.5](/filings/0001628280-24-047204.md) | [(3.3)](/filings/0001628280-25-015469.md) | [3.8](/filings/0001628280-24-047204.md) | [22.9](/filings/0001628280-24-047204.md) | [20.2](/filings/0001628280-24-047204.md) | [12.4](/filings/0001493152-26-016259.md) | [21.8](/filings/0001628280-25-025004.md) | [26.1](/filings/0001628280-25-039914.md) | [1,553](/filings/0001628280-26-001793.md) | [1,152](/filings/0001493152-26-038732.md) | [890](/filings/0001493152-26-024169.md) | [668](/filings/0001493152-26-038732.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Current portion of debt: not reported - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(0.4) d](/filings/0001628280-24-047204.md) | [(0.4) d](/filings/0001628280-25-015469.md) | [(0.5)](/filings/0001628280-25-025004.md) | [0.1 d](/filings/0001628280-25-039914.md) | [4.2 d](/filings/0001628280-26-001793.md) | [(2.0) d](/filings/0001493152-26-016259.md) | [(1.4)](/filings/0001493152-26-024169.md) | [(5.3) d](/filings/0001493152-26-038732.md) | [(8.7) d](/filings/0001628280-26-001793.md) | [8.3 d](/filings/0001493152-26-016259.md) | [(12.3)](/filings/0001493152-26-024169.md) | [(6.2) d](/filings/0001493152-26-038732.md) | | Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [(0.0) d](/filings/0001493152-26-016259.md) | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ## Shares | Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [3.2](/filings/0001628280-23-038956.md) | [3.2](/filings/0001628280-24-020286.md) | [3.7](/filings/0001628280-24-037717.md) | [4.2](/filings/0001628280-24-047204.md) | [6.3](/filings/0001628280-25-025004.md) | [8.4](/filings/0001628280-25-039914.md) | [12.8](/filings/0001628280-26-001793.md) | [15.6](/filings/0001493152-26-024169.md) | [18.6](/filings/0001493152-26-038732.md) | [169](/filings/0001628280-26-001793.md) | [127](/filings/0001493152-26-024169.md) | [137](/filings/0001493152-26-038732.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 139,836,511 at 2026-08-12, from the cover of the [10-Q filed 2026-08-17](/filings/0001493152-26-038732.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.